The emerging treatment of this peptide represents a exciting breakthrough in the handling of type 2 diabetes. Different to existing therapies, tirzepatide affects two pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide240646.yomoblog.com/49398462/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment